{"id": 1383138184171782144, "geo": null, "lang": "en", "text": "RT @trishgreenhalgh: Missed this earlier today. Your brown inhaler might make you better quicker! \nhttps://t.co/lY1Ht6hCak", "user": {"id": 2932558313, "url": null, "lang": null, "name": "Dr Philippa Whitford", "id_str": "2932558313", "location": "Troon", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Fri Dec 19 20:25:00 +0000 2014", "utc_offset": null, "description": "I\u2019m delighted to have been re-elected as MP for Central Ayrshire and will do my best to assist constituents and work with local community groups and industries.", "geo_enabled": true, "screen_name": "Dr_PhilippaW", "listed_count": 458, "friends_count": 1059, "is_translator": false, "notifications": null, "statuses_count": 35566, "default_profile": true, "followers_count": 36646, "translator_type": "none", "favourites_count": 24201, "profile_image_url": "http://pbs.twimg.com/profile_images/789857935648256000/xw9lKbMI_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/2932558313/1419023936", "profile_link_color": "1DA1F2", "profile_text_color": "333333", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/789857935648256000/xw9lKbMI_normal.jpg", "profile_background_color": "C0DEED", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "C0DEED", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1383138184171782144", "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>", "entities": {"urls": [{"url": "https://t.co/lY1Ht6hCak", "indices": [99, 122], "display_url": "twitter.com/OxPrimaryCare/\u2026", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809?s=20"}], "symbols": [], "hashtags": [], "user_mentions": [{"id": 462021312, "name": "Trisha Greenhalgh \ud83d\ude37 #CovidIsAirborne", "id_str": "462021312", "indices": [3, 19], "screen_name": "trishgreenhalgh"}]}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Fri Apr 16 19:20:15 +0000 2021", "coordinates": null, "quote_count": 0, "reply_count": 0, "contributors": null, "filter_level": "low", "timestamp_ms": "1618600815228", "quoted_status": {"id": 1381611323088375809, "geo": null, "lang": "en", "text": "BREAKING NEWS: PRINCIPLE trial reports the corticosteroid budesonide is the first widely available, inexpensive dru\u2026 https://t.co/iUeWJxkIzr", "user": {"id": 856667810, "url": "http://www.phc.ox.ac.uk", "lang": null, "name": "OxPrimaryCareSci", "id_str": "856667810", "location": "University of Oxford", "verified": false, "following": null, "protected": false, "time_zone": null, "created_at": "Mon Oct 01 16:48:14 +0000 2012", "utc_offset": null, "description": "Nuffield Department of Primary Care Health Sciences - applied research & teaching for better care in the community. Tweets from our multidisciplinary team.", "geo_enabled": true, "screen_name": "OxPrimaryCare", "listed_count": 82, "friends_count": 1902, "is_translator": false, "notifications": null, "statuses_count": 3534, "default_profile": false, "followers_count": 5031, "translator_type": "none", "favourites_count": 1674, "profile_image_url": "http://pbs.twimg.com/profile_images/1148883310065672192/7t9HJBdF_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/856667810/1611233525", "profile_link_color": "8A1751", "profile_text_color": "333333", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1148883310065672192/7t9HJBdF_normal.jpg", "profile_background_color": "ADCFE6", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "FFFFFF", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1381611323088375809", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/iUeWJxkIzr", "indices": [117, 140], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1381611323088375809"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Mon Apr 12 14:13:03 +0000 2021", "coordinates": null, "quote_count": 92, "reply_count": 35, "contributors": null, "filter_level": "low", "retweet_count": 442, "extended_tweet": {"entities": {"urls": [{"url": "https://t.co/nTBxI5Iu0u", "indices": [256, 279], "display_url": "principletrial.org/news/asthma-dr\u2026", "expanded_url": "https://www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19"}], "media": [{"id": 1381607666359885830, "url": "https://t.co/nQoiFkXpI5", "type": "photo", "sizes": {"large": {"h": 512, "w": 1024, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 512, "w": 1024, "resize": "fit"}}, "id_str": "1381607666359885830", "indices": [280, 303], "media_url": "http://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg", "description": "Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery time in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1779 patients.", "display_url": "pic.twitter.com/nQoiFkXpI5", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809/photo/1", "media_url_https": "https://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg"}], "symbols": [], "hashtags": [{"text": "primarycare", "indices": [218, 230]}], "user_mentions": []}, "full_text": "BREAKING NEWS: PRINCIPLE trial reports the corticosteroid budesonide is the first widely available, inexpensive drug found to shorten recovery time in non-hospitalised patients with COVID-19. It is now available in UK #primarycare on a case-by-case basis.\nhttps://t.co/nTBxI5Iu0u https://t.co/nQoiFkXpI5", "extended_entities": {"media": [{"id": 1381607666359885830, "url": "https://t.co/nQoiFkXpI5", "type": "photo", "sizes": {"large": {"h": 512, "w": 1024, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 512, "w": 1024, "resize": "fit"}}, "id_str": "1381607666359885830", "indices": [280, 303], "media_url": "http://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg", "description": "Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery time in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1779 patients.", "display_url": "pic.twitter.com/nQoiFkXpI5", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809/photo/1", "media_url_https": "https://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg"}]}, "display_text_range": [0, 279]}, "favorite_count": 721, "is_quote_status": false, "display_text_range": [0, 140], "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "retweet_count": 0, "favorite_count": 0, "is_quote_status": true, "quoted_status_id": 1381611323088375809, "retweeted_status": {"id": 1381700598618320905, "geo": null, "lang": "en", "text": "Missed this earlier today. Your brown inhaler might make you better quicker! \nhttps://t.co/lY1Ht6hCak", "user": {"id": 462021312, "url": "https://www.phc.ox.ac.uk/team/trish-greenhalgh", "lang": null, "name": "Trisha Greenhalgh \ud83d\ude37 #CovidIsAirborne", "id_str": "462021312", "location": "Oxford, England", "verified": true, "following": null, "protected": false, "time_zone": null, "created_at": "Thu Jan 12 13:31:58 +0000 2012", "utc_offset": null, "description": "Prof of Prim Care, Oxford. Alert me if someone needs unblocking https://scholar.google.co.uk/citations?sortby=pubdate&hl=en&user=8KQwEGcAAAAJ&view_op=list_works", "geo_enabled": true, "screen_name": "trishgreenhalgh", "listed_count": 1394, "friends_count": 2863, "is_translator": false, "notifications": null, "statuses_count": 69273, "default_profile": false, "followers_count": 122403, "translator_type": "none", "favourites_count": 52451, "profile_image_url": "http://pbs.twimg.com/profile_images/1290196939988963333/xWyYLPgy_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/462021312/1580549568", "profile_link_color": "1B95E0", "profile_text_color": "7B7B9C", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": true, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1290196939988963333/xWyYLPgy_normal.jpg", "profile_background_color": "183962", "profile_sidebar_fill_color": "5C80B2", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme19/bg.gif", "profile_sidebar_border_color": "790A5B", "profile_use_background_image": true, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme19/bg.gif"}, "place": null, "id_str": "1381700598618320905", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/lY1Ht6hCak", "indices": [78, 101], "display_url": "twitter.com/OxPrimaryCare/\u2026", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809?s=20"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": false, "created_at": "Mon Apr 12 20:07:48 +0000 2021", "coordinates": null, "quote_count": 4, "reply_count": 16, "contributors": null, "filter_level": "low", "quoted_status": {"id": 1381611323088375809, "geo": null, "lang": "en", "text": "BREAKING NEWS: PRINCIPLE trial reports the corticosteroid budesonide is the first widely available, inexpensive dru\u2026 https://t.co/iUeWJxkIzr", "user": {"id": 856667810, "url": "http://www.phc.ox.ac.uk", "lang": null, "name": "OxPrimaryCareSci", "id_str": "856667810", "location": "University of Oxford", "verified": false, "following": null, "protected": false, "time_zone": null, "created_at": "Mon Oct 01 16:48:14 +0000 2012", "utc_offset": null, "description": "Nuffield Department of Primary Care Health Sciences - applied research & teaching for better care in the community. Tweets from our multidisciplinary team.", "geo_enabled": true, "screen_name": "OxPrimaryCare", "listed_count": 82, "friends_count": 1902, "is_translator": false, "notifications": null, "statuses_count": 3534, "default_profile": false, "followers_count": 5031, "translator_type": "none", "favourites_count": 1674, "profile_image_url": "http://pbs.twimg.com/profile_images/1148883310065672192/7t9HJBdF_normal.jpg", "profile_banner_url": "https://pbs.twimg.com/profile_banners/856667810/1611233525", "profile_link_color": "8A1751", "profile_text_color": "333333", "follow_request_sent": null, "contributors_enabled": false, "default_profile_image": false, "withheld_in_countries": [], "profile_background_tile": false, "profile_image_url_https": "https://pbs.twimg.com/profile_images/1148883310065672192/7t9HJBdF_normal.jpg", "profile_background_color": "ADCFE6", "profile_sidebar_fill_color": "DDEEF6", "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png", "profile_sidebar_border_color": "FFFFFF", "profile_use_background_image": false, "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png"}, "place": null, "id_str": "1381611323088375809", "source": "<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>", "entities": {"urls": [{"url": "https://t.co/iUeWJxkIzr", "indices": [117, 140], "display_url": "twitter.com/i/web/status/1\u2026", "expanded_url": "https://twitter.com/i/web/status/1381611323088375809"}], "symbols": [], "hashtags": [], "user_mentions": []}, "favorited": false, "retweeted": false, "truncated": true, "created_at": "Mon Apr 12 14:13:03 +0000 2021", "coordinates": null, "quote_count": 92, "reply_count": 35, "contributors": null, "filter_level": "low", "retweet_count": 442, "extended_tweet": {"entities": {"urls": [{"url": "https://t.co/nTBxI5Iu0u", "indices": [256, 279], "display_url": "principletrial.org/news/asthma-dr\u2026", "expanded_url": "https://www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19"}], "media": [{"id": 1381607666359885830, "url": "https://t.co/nQoiFkXpI5", "type": "photo", "sizes": {"large": {"h": 512, "w": 1024, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 512, "w": 1024, "resize": "fit"}}, "id_str": "1381607666359885830", "indices": [280, 303], "media_url": "http://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg", "description": "Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery time in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1779 patients.", "display_url": "pic.twitter.com/nQoiFkXpI5", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809/photo/1", "media_url_https": "https://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg"}], "symbols": [], "hashtags": [{"text": "primarycare", "indices": [218, 230]}], "user_mentions": []}, "full_text": "BREAKING NEWS: PRINCIPLE trial reports the corticosteroid budesonide is the first widely available, inexpensive drug found to shorten recovery time in non-hospitalised patients with COVID-19. It is now available in UK #primarycare on a case-by-case basis.\nhttps://t.co/nTBxI5Iu0u https://t.co/nQoiFkXpI5", "extended_entities": {"media": [{"id": 1381607666359885830, "url": "https://t.co/nQoiFkXpI5", "type": "photo", "sizes": {"large": {"h": 512, "w": 1024, "resize": "fit"}, "small": {"h": 340, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 512, "w": 1024, "resize": "fit"}}, "id_str": "1381607666359885830", "indices": [280, 303], "media_url": "http://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg", "description": "Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery time in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK's PRINCIPLE trial in 1779 patients.", "display_url": "pic.twitter.com/nQoiFkXpI5", "expanded_url": "https://twitter.com/OxPrimaryCare/status/1381611323088375809/photo/1", "media_url_https": "https://pbs.twimg.com/media/Eyx02jxWYAYu-ys.jpg"}]}, "display_text_range": [0, 279]}, "favorite_count": 721, "is_quote_status": false, "display_text_range": [0, 140], "possibly_sensitive": false, "in_reply_to_user_id": null, "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "in_reply_to_status_id_str": null}, "retweet_count": 100, "favorite_count": 310, "is_quote_status": true, "quoted_status_id": 1381611323088375809, "possibly_sensitive": false, "in_reply_to_user_id": null, "quoted_status_id_str": "1381611323088375809", "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "quoted_status_permalink": {"url": "https://t.co/lY1Ht6hCak", "display": "twitter.com/OxPrimaryCare/\u2026", "expanded": "https://twitter.com/OxPrimaryCare/status/1381611323088375809?s=20"}, "in_reply_to_status_id_str": null}, "possibly_sensitive": false, "in_reply_to_user_id": null, "quoted_status_id_str": "1381611323088375809", "in_reply_to_status_id": null, "in_reply_to_screen_name": null, "in_reply_to_user_id_str": null, "quoted_status_permalink": {"url": "https://t.co/lY1Ht6hCak", "display": "twitter.com/OxPrimaryCare/\u2026", "expanded": "https://twitter.com/OxPrimaryCare/status/1381611323088375809?s=20"}, "in_reply_to_status_id_str": null}